Literature DB >> 27095809

Initial presentation of CNS-restricted acute lymphoblastic B cell leukaemia as peripheral polyneuropathy.

Guilherme Piovezani Ramos1, Jose C Villasboas Bisneto2, Dong Chen2, Animesh Pardanani2.   

Abstract

We report a case of a 58-year-old woman who presented with a 1-month course of progressive lower and upper extremity weakness in addition to binocular diplopia. Diagnostic lumbar puncture revealed atypical lymphoid cells with 28% blasts. Immunophenotype was consistent with B cell acute lymphoblastic leukaemia (B-ALL). Further work up showed no systemic involvement but extensive thoracolumbar-sacral leptomeningeal disease. The patient was treated with several courses of intrathecal and systemic chemotherapy followed by craniospinal irradiation for consolidation. There was initial steady improvement in neurological symptoms and leptomeningeal disease, the latter being ascertained through radiological studies and cerebrospinal fluid examination. After 10 months of response, the patient relapsed with central nervous system (CNS) and systemic disease. B-ALL is a rare precursor lymphoid neoplasm that generally presents with systemic disease. While CNS involvement is not uncommon, isolated involvement of this compartment without systemic disease is exceedingly rare. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2016        PMID: 27095809      PMCID: PMC4840636          DOI: 10.1136/bcr-2016-214645

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  7 in total

1.  Hematologic neoplasia and the central nervous system.

Authors:  R L Sham; P D Phatak; P A Kouides; J A Janas; V J Marder
Journal:  Am J Hematol       Date:  1999-12       Impact factor: 10.047

Review 2.  Central nervous system disease in acute lymphoblastic leukemia: prophylaxis and treatment.

Authors:  Ching-Hon Pui
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2006

Review 3.  Acute lymphoblastic leukaemia.

Authors:  Hiroto Inaba; Mel Greaves; Charles G Mullighan
Journal:  Lancet       Date:  2013-03-22       Impact factor: 79.321

Review 4.  Primary lymphoma of the central nervous system: epidemiology, pathology and current approaches to diagnosis, prognosis and treatment.

Authors:  James Rubenstein; Andrés J M Ferreri; Stefania Pittaluga
Journal:  Leuk Lymphoma       Date:  2008

Review 5.  Primary leptomeningeal lymphoma: report of 9 cases, diagnosis with immunocytochemical analysis, and review of the literature.

Authors:  D H Lachance; B P O'Neill; D R Macdonald; K A Jaeckle; T E Witzig; C Y Li; J B Posner
Journal:  Neurology       Date:  1991-01       Impact factor: 9.910

6.  Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis: results from the international ALL trial MRC UKALL XII/ECOG E2993.

Authors:  Hillard M Lazarus; Susan M Richards; Raj Chopra; Mark R Litzow; Alan K Burnett; Peter H Wiernik; Ian M Franklin; Martin S Tallman; Lucy Cook; Georgina Buck; I Jill Durrant; Jacob M Rowe; Anthony H Goldstone
Journal:  Blood       Date:  2006-03-23       Impact factor: 22.113

Review 7.  Central nervous system involvement in adult acute lymphoblastic leukemia: diagnostic tools, prophylaxis, and therapy.

Authors:  Maria Ilaria Del Principe; Luca Maurillo; Francesco Buccisano; Giuseppe Sconocchia; Mariagiovanna Cefalo; Giovanna De Santis; Ambra Di Veroli; Concetta Ditto; Daniela Nasso; Massimiliano Postorino; Marco Refrigeri; Cristina Attrotto; Giovanni Del Poeta; Francesco Lo-Coco; Sergio Amadori; Adriano Venditti
Journal:  Mediterr J Hematol Infect Dis       Date:  2014-11-01       Impact factor: 2.576

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.